Assessing Satisfaction With Contraceptive Counseling Using Telephone Versus Video Telehealth Visits
Pilot Randomized Controlled Trial to Assess Satisfaction With Contraceptive Counseling Using Telephone Versus Video Telehealth Visits
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Rachel Paul, MPH
- Phone Number: (314) 747-8176
- Email: paulr@wustl.edu
Study Contact Backup
- Name: Megan Dorsey, MPH
- Phone Number: (314) 273-2561
- Email: m.dorsey@wustl.edu
Study Locations
-
-
Missouri
-
Saint Louis, Missouri, United States, 63110
- Washington University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Able to speak and read English
- Access to video-capable technology
Exclusion Criteria:
- Incarceration
- Unable to provide informed consent secondary to language barrier or cognitive limitation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Video
Patients will complete contraceptive counseling using a video-based platform.
Patients and counselors will have an audio and video connection.
|
Patients will receive contraceptive counseling to review all available contraceptive methods prior to their visit with a clinician.
|
|
Experimental: Telephone
Patients will complete contraceptive counseling on a telephone call.
Patients and counselors will have an audio connection only.
|
Patients will receive contraceptive counseling to review all available contraceptive methods prior to their visit with a clinician.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Satisfaction Assessed by IQFP
Time Frame: Baseline
|
Interpersonal Quality in Family Planning (IQFP) scale Continuous score: 11-55, higher scores indicate higher patient satisfaction Dichotomous: highest score (55) versus lower scores, highest score indicates highest patient satisfaction |
Baseline
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
% of Patients Receiving Desired Contraceptive Method Assessed by Medical Record Review
Time Frame: 30 Days Post Baseline
|
30 Days Post Baseline
|
|
|
% of Patients Reporting Barriers to Technology Use Assessed by Baseline Questionnaire
Time Frame: Baseline
|
Percentage of patients reporting limited access to mobile telephone or computer with video capabilities, unreliable telephone or internet service, and environmental distractors (i.e.
loud noises, lack of privacy)
|
Baseline
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Jennifer A Reeves, MD, MPH, Washington University School of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 202203067
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.